JPWO2022047249A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022047249A5
JPWO2022047249A5 JP2023513670A JP2023513670A JPWO2022047249A5 JP WO2022047249 A5 JPWO2022047249 A5 JP WO2022047249A5 JP 2023513670 A JP2023513670 A JP 2023513670A JP 2023513670 A JP2023513670 A JP 2023513670A JP WO2022047249 A5 JPWO2022047249 A5 JP WO2022047249A5
Authority
JP
Japan
Prior art keywords
amount
administration
hydroxypropyl
cyclodextrin
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543131A (ja
JP2023543131A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048084 external-priority patent/WO2022047249A1/en
Publication of JP2023543131A publication Critical patent/JP2023543131A/ja
Publication of JPWO2022047249A5 publication Critical patent/JPWO2022047249A5/ja
Publication of JP2023543131A5 publication Critical patent/JP2023543131A5/ja
Pending legal-status Critical Current

Links

JP2023513670A 2020-08-27 2021-08-27 シクロデキストリンによる心血管疾患の治療方法 Pending JP2023543131A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
US63/071,257 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (3)

Publication Number Publication Date
JP2023543131A JP2023543131A (ja) 2023-10-13
JPWO2022047249A5 true JPWO2022047249A5 (https=) 2024-08-13
JP2023543131A5 JP2023543131A5 (https=) 2024-08-13

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513670A Pending JP2023543131A (ja) 2020-08-27 2021-08-27 シクロデキストリンによる心血管疾患の治療方法

Country Status (14)

Country Link
US (2) US20240000826A1 (https=)
EP (1) EP4203974A4 (https=)
JP (1) JP2023543131A (https=)
KR (1) KR20230104119A (https=)
CN (1) CN116322644A (https=)
AU (1) AU2021331487A1 (https=)
CA (1) CA3189915A1 (https=)
CO (1) CO2023003656A2 (https=)
CR (1) CR20230135A (https=)
IL (1) IL300805A (https=)
JO (1) JOP20230043A1 (https=)
MX (1) MX2023002418A (https=)
PE (1) PE20231169A1 (https=)
WO (1) WO2022047249A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
CN104244956B (zh) * 2012-04-13 2020-04-17 L&F研究有限公司 使用环糊精的方法

Similar Documents

Publication Publication Date Title
Gülberg et al. Long‐term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
US5849740A (en) Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
JP2020521755A5 (https=)
JP2014185161A (ja) シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤
Pasternak et al. Enhanced rate of progression of coronary artery disease following aortocoronary saphenous vein bypass surgery
KR102008826B1 (ko) 나토키나제와 항염증제를 유효성분으로 포함하는 혈소판 응집 억제용 또는 혈전용해용 의약 조성물
JPWO2022047249A5 (https=)
EP1190714A2 (en) Method for the treatment of thromboembolic disorders in patients with aspirin resistance
Jacob Pulse steroids in hematologic diseases
US20070155828A1 (en) Coumarin analog compounds for safer anticoagulant treatment
JPS6150927B2 (https=)
Porter et al. Iron chelation
CN104000814B (zh) 一种防治痛风性关节炎的药物组合物及其用途
AU2002220960A1 (en) Regeneration of blood vessels
KR100895031B1 (ko) 지질 농후 플라크의 감소, 안정화 및 파열 방지 방법
JPWO2022047241A5 (https=)
JP2020045332A (ja) 慢性便秘症を治療するための医薬組成物
WO1999030698A1 (en) A drug for treating diabetic nephrosis and delaying renal failure
Ragoonanan et al. Clinical update on vasopressors and titration strategies
AU2008201290B2 (en) Therapeutic treatment
JP2000511550A (ja) リポタンパク質(a)の血漿水準を低下させるための薬剤の製造のための、ラロキシフェン及び類縁化合物の使用
JP2532918B2 (ja) グアニジノ安息香酸誘導体を有効成分として含有する抗動脈硬化剤
CN118715017A (zh) 用2-羟基丙基-β-环糊精治疗高甘油三酯血症
CN1019545B (zh) 制备用于治疗心律不齐的含有喹啉衍生物的组合物的方法
JPWO2023156970A5 (https=)